CMRE
Costamare Inc.
CMRE's fundamentals are mixed: its operating margin rose 13 points to 45%, but revenue fell 42%. At 5.1x earnings, it's trading in line with its usual 4.9x. Analysts expect earnings to hold roughly steady.
EOSE
Eos Energy Enterprises, Inc.
There isn't enough reported data to score EOSE yet.
CMRE Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Strong | |
| Weak | |
| Stable |
CMRE's profitability is currently strong, and its balance sheet is stable, but its revenue and cash flow are under pressure.
EOSE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
EOSE's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
CMRE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 2.6x | $6.65 | -50% |
| Fair | 4.9x | $12.61 | -4.8% |
| Current | 5.1x | $13.24 | โ |
| Forward | 5.4x | $13.24 | โ |
| Expensive | 6.5x | $16.77 | +27% |
Historical ranges are pointers, not guarantees.
CMRE's PE is in its fair range at 5.1x. On analysts' estimates for next year's earnings, today's price would be 5.4x.
EOSE PE Valuation
EOSE has no meaningful PE right now: it lost money over the past year.
CMRE Forward outlook
| Metric | Outlook |
|---|---|
| Deteriorating | |
| Stable | |
| Growth | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect CMRE's revenue to grow, but its profitability to weaken.
EOSE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect EOSE's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
CMRE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.45 | -5.4% |
| Q3 2026 | $2.59 | +3.6% |
| Q2 2026 | $2.63 | +11% |
| Q1 2026 | $2.68 | +9.8% |
| Q4 2025 | $2.85 | +17% |
| Q3 2025 | $2.50 | -17% |
| Q2 2025 | $2.36 | -16% |
| Q1 2025 | $2.44 | -5.1% |
| Q4 2024 | $2.44 | -17% |
CMRE has the stronger earnings trend. Trailing diluted EPS is up 3.6% for CMRE versus EOSE down 224%.
EOSE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2023 | -$2.69 | +$0.85 |
| Q2 2023 | -$3.76 | -$1.00 |
| Q1 2023 | -$3.65 | -$0.86 |
| Q4 2022 | -$3.68 | -$1.32 |
| Q3 2022 | -$3.54 | +$5.19 |
EOSE is still losing money, but less than at its worst: $4.55 per share over the past year, against $8.73 at its worst in late 2021.
CMRE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $212.1M | -5.8% |
| Q2 2026 | $200.8M | -4.8% |
| Q1 2026 | $201.6M | -55% |
| Q4 2025 | $212M | -61% |
| Q3 2025 | $225.2M | -59% |
| Q2 2025 | $210.9M | -3.2% |
| Q1 2025 | $446.2M | -6.1% |
| Q4 2024 | $548.4M | +11% |
CMRE's revenue has slid since its 2024 peak: $212M last quarter, down 5.8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 43% | -9 points |
| Q2 2026 | 45% | -5 points |
| Q1 2026 | 44% | +20 points |
| Q4 2025 | 48% | +24 points |
| Q3 2025 | 52% | +33 points |
| Q2 2025 | 50% | -4.3 points |
| Q1 2025 | 24% | +2.4 points |
| Q4 2024 | 23% | +1.7 points |
CMRE has the edge over EOSE on profitability, with a higher operating margin.
EOSE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $82.7M | +171% |
| Q2 2026 | $68.8M | +351% |
| Q1 2026 | $57M | +445% |
| Q4 2025 | $58M | +700% |
| Q3 2025 | $30.5M | +3473% |
| Q2 2025 | $15.2M | +1597% |
| Q1 2025 | $10.5M | +58% |
| Q4 2024 | $7.3M | +9.7% |
EOSE has the edge over CMRE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -96% | +105 points |
| Q2 2026 | -122% | +297 points |
| Q1 2026 | -139% | +367 points |
| Q4 2025 | -140% | +573 points |
| Q3 2025 | -201% | +6044 points |
| Q2 2025 | -419% | +2815 points |
| Q1 2025 | -506% | +117 points |
| Q4 2024 | -713% | -74 points |
EOSE's operating margin was โ96% last quarter, up 105 points from the same quarter a year ago, near the top of its range since 2019.
CMRE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$255.9M | -187% |
| Q1 2026 | $25.5M | -81% |
| Q4 2025 | $66.2M | +174% |
| Q3 2025 | $30.9M | -52% |
| Q2 2025 | $295M | +$295.5M |
| Q1 2025 | $137.3M | +47% |
| Q4 2024 | $24.1M | +$90.5M |
| Q3 2024 | $64.9M | +$144.3M |
CMRE has the edge over EOSE on cash flow, with more consistent year-over-year improvement.
EOSE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$105.1M | -$22.4M |
| Q2 2026 | -$107.4M | -$34.3M |
| Q1 2026 | -$154.8M | -$121M |
| Q4 2025 | -$75.2M | -$19.5M |
| Q3 2025 | -$82.7M | -$28.5M |
| Q2 2025 | -$73.2M | -$40.6M |
| Q1 2025 | -$33.8M | +$10.7M |
| Q4 2024 | -$55.8M | -$10.2M |
EOSE has burned cash in almost every quarter: โ$443M over the past year, against โ$246M the year before.
CMRE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.2x | Moderate |
| Q2 2026 | 2.1x | Moderate |
| Q1 2026 | 1.6x | Healthy |
| Q4 2025 | 1.7x | Healthy |
| Q3 2025 | 1.9x | Healthy |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 2.6x | Moderate |
| Q4 2024 | 2.8x | Moderate |
CMRE's net debt is about 2.2 years of its operating earnings (EBITDA), up from 1.9 years a year ago.
EOSE Net Leverage
EOSE's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CMRE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.5 | Neutral |
| Stochastic | 16.2 | Oversold |
CMRE's weekly RSI is 39 (neutral) and its Stochastic is 16 (oversold).
EOSE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.5 | Neutral |
| Stochastic | 7.4 | Oversold |
EOSE's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
CMRE PE vs Industrials Sector
| Metric | CMRE | Sector median | Relative |
|---|---|---|---|
| PE | 5.1x | 24x | 79% below |
| PE % | 54 | 58 | 4 pts below |
CMRE is trading at 5.1x earnings, a 79% discount to the Industrials sector's median of 24x.
EOSE PE vs Industrials Sector
EOSE has no meaningful PE right now: it lost money over the past year.
CMRE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $14.2 | 6.4% below |
| 20 week MA | $14.8 | 10% below |
| 50 week MA | $15.7 | 16% below |
| 100 week MA | $13.3 | 0.4% below |
| 200 week MA | $12.4 | 6.9% above |
CMRE has the edge over EOSE on trend strength, trading above more of its moving averages.
EOSE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.24 | 19% below |
| 20 week MA | $3.28 | 45% below |
| 50 week MA | $7.01 | 74% below |
| 100 week MA | $7.10 | 75% below |
| 200 week MA | $4.53 | 60% below |
EOSE is in a downtrend: it's below all five of its weekly moving averages, and 60% below its 200-week average.
CMRE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.59 | $7.84 | -18% |
| 2021 | $7.84 | $12.2 | +56% |
| 2022 | $12.2 | $9.06 | -26% |
| 2023 | $9.06 | $10.4 | +15% |
| 2024 | $10.4 | $12.8 | +23% |
| 2025 | $12.8 | $15.7 | +23% |
| 2026 YTD | $15.7 | $13.2 | -16% |
CMRE has the edge over EOSE on returns for 2026, with the stronger performance.
EOSE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.72 | $19.2 | +98% |
| 2021 | $19.2 | $8.57 | -55% |
| 2022 | $8.57 | $1.08 | -87% |
| 2023 | $1.08 | $1.09 | +0.9% |
| 2024 | $1.09 | $5.17 | +374% |
| 2025 | $5.17 | $11.9 | +129% |
| 2026 YTD | $11.9 | $1.81 | -85% |
EOSE's yearly returns have swung widely, from +374% in 2024 to โ87% in 2022. It's down 85% so far in 2026.